151 results on '"Olivola, Enrica"'
Search Results
2. Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation
3. Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?
4. The Italian tremor Network (TITAN): rationale, design and preliminary findings
5. Functional motor phenotypes: to lump or to split?
6. An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease
7. Elderly Onset of Functional Motor Disorders: Clinical Correlates from the Italian Registry
8. Correction to: The Italian tremor Network (TITAN): rationale, design and preliminary findings
9. Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
10. Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study
11. Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study.
12. Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson's disease
13. Elderly Onset of Functional Motor Disorders: Clinical Correlates from the Italian Registry
14. Facial emotion recognition in Parkinson's disease: methodological, clinical, and pathophysiological factors
15. Contributors
16. Validation of the Italian version of the PSP Quality of Life questionnaire
17. Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy
18. Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease
19. Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment
20. Effects of dopaminergic treatment on inhibitory control differ across Hoehn and Yahr stages of Parkinson's disease.
21. Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction?
22. Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study
23. Data-driven clustering of combined Functional Motor Disorders based on the Italian registry
24. Correction to: Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies
25. Clinical correlates of "pure" essential tremor: the TITAN study.
26. A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort
27. Functional gait disorders: Demographic and clinical correlations
28. Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: A challenge for the 6-OHDA model?
29. Autonomic Function Tests and MIBG in Parkinsonʼs Disease: Correlation to Disease Duration and Motor Symptoms
30. Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson’s disease
31. CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD
32. Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson’s Disease
33. Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology
34. Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
35. Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study
36. Parkinson's Disease in Pregnancy: A Case Report and Review of the Literature
37. Early‐Stage Parkinson's Patients Show Selective Impairment in Reactive But Not Proactive Inhibition
38. Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies
39. Progressive Supranuclear Palsy Quality of Life Scale--Italian Version
40. Parkinsonism Carers Quality of Life--Italian Version
41. Effects of Prismatic Lenses on Lateral Axial Dystonia in Parkinson's Disease: A Pilot Study.
42. Early-stage Parkinson's patients show selective impairment in reactive but not proactive inhibition.
43. Cerebrospinal-fluid Alzheimer’s Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson’s Disease Patients
44. Low Serum 25(OH)D Levels in Parkinson âÂÂs Disease; a Non Specific Marker of Neurodegeneration?
45. Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease
46. Catecholamine-Based Treatment in AD Patients: Expectations and Delusions
47. Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart
48. Strength and Weaknesses of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Possible Detection of Overlaps with Frailty Process
49. Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson’s disease
50. A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.